Nesosteine, which is active on airway secretions, has been studied by assessment of the mucociliary clearance of the frog palate. Sputum was collected from patients admitted to hospital with acute exacerbations of chronic bronchitis with mucous expectoration. The relative speed of transport was measured for each patient before and after oral administration of 600mg/day nesosteine. A significant increase in the mucus transport rate was found at the end of treatment
Get full access to this article
View all access options for this article.
References
1.
HotzingerH: A controlled clinical trial with the new mucolytic agent CO/1177. Med Praxis1985; 6: 1–4.
2.
WischnikA: Mucolytic activity of CO/1177 in patients with hypersecretive bronchitis. Med Praxis1985; 6: 5–8.
3.
PfaendnerK: Effectiveness of CO/1177, a new mucolytic agent, in patients with chronic bronchitis. Med Praxis1985; 6: 9–13.
4.
SiquetJ: Clinical trial with a new mucolytic agent (CO/1177) in the treatment of patients with chronic bronchitis. Acta Ther1985; 11: 61–66.
5.
DulfanoMJAlderKB: Physical properties of sputum. VII Rheologic properties and mucociliary transport. Am Rev Respir Dis1975; 112: 341–347.
6.
KingMGilboaAMeyerFA: On the transport of mucus and its rheological stimulation in ciliated systems. Am Rev Respir Dis1974; 110: 740–745.
7.
SadeJEliezerNSilbergergA: The role of mucus in transport by cilia. Am Rev Respir Dis1970; 102: 48–52.
8.
PuchelleEGirardFZahmJM: Rheologie des secretions bronchiques et transport mucociliaire. Bull Eur Physiopathol Respir1976; 12: 771–779.
9.
PuchelleEGirardFSadoulP: Rheologie des secretions bronchiques et clearance mucociliaire. Remarques preliminaires. Am Int Med1976; 127: 321–325.
10.
AllegraLBossiRBragaPC: Action of sobrerol on mucociliary transport. Respiration1981; 42: 105–109.